TransMedics Group, Inc.
TMDX
DELAYED 1 MONTH
13 insider filings · Latest: May 20, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6 11:12 PM | Stephanie LovellDirector | Sale | 1,193 | $149.62 | $178.5K | 2,866(D) | View → |
| Mar 4, 2026 | Mar 6 11:09 PM | David WeillDirector | Sale | 3,571 | $146.82 | $524.3K | 12,134(D) | View → |
| Mar 4, 2026 | Mar 5 2:40 AM | Gerardo HernandezChief Financial Officer | Sale | 7,236 | $147.21 | $1.1M | 14,689(D) | View → |
| Mar 2, 2026 | Mar 5 2:40 AM | Gerardo HernandezChief Financial Officer | Sale | 375 | $139.12 | $52.2K | 14,689(D) | View → |
| Mar 2, 2026 | Mar 5 1:40 AM | Anil P. RanganathSenior Vice President, General Counsel and Secretary | Sale | 864 | $139.12 | $120.2K | 13,091(D) | View → |
| Mar 2, 2026 | Mar 5 1:40 AM | Nicholas CorcoranSVP of Supply Chain and Operations | Sale | 2,966 | $139.12 | $412.6K | 29,831(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 21 10:47 PM | Matthew S. ForsythSenior Vice President, General Counsel and Secretary | Grant/Award | 23,171 | $66.13 | 23,171(D) | View → |
| Mar 4, 2026 | Mar 6 11:09 PM | David WeillDirector | Option Exercise | 3,571 | $14.20 | 1,429(D) | View → |
| Mar 4, 2026 | Mar 5 2:40 AM | Gerardo HernandezChief Financial Officer | Option Exercise | 7,236 | $77.12 | 13,010(D) | View → |